Niagen Bioscience
Builds Niagen-based supplements, ingredients, and clinical NAD+ channels.
$3.30
After-hours close+0.00 (+0.15%)
At close$3.30(+2.65%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions —Insiders 1.35%
Shares outstanding 79.64M · Float 52.48M · 65.9% free float
Institutions13F
No 13F holders on record.
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Robert N. Fried | director, officer: Chief Executive Officer | 1.06M | 1.33% | Jul 8, 2026 |
| Ozan Pamir | officer: Chief Financial Officer | 13.8K | 0.02% | Jul 8, 2026 |
| Carlos Luis Lopez | officer: SVP, General Counsel | 4.6K | 0.01% | Jul 8, 2026 |
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Nov 14, 2025 | Ozan Pamirofficer: Chief Financial Officer | Purchase · 2 lots | 6,685 | $6.82 | 9,593 |
CongressHouse and Senate disclosures
Not reported.